S. 1323 · 117th Congress · Senate

End Price Gouging for Medications Act

Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
Apr 22, 21
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

End Price Gouging for Medications Act

This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.

Action Timeline

2
  1. APR 22, 2021IntroReferral

    Introduced in Senate

  2. APR 22, 2021IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees

1

Health, Education, Labor, and Pensions Committee

sshr00

Referred: Apr 22, 2021

Active